These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 17066438

  • 1. 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production.
    Suzuki T, Miki Y, Moriya T, Akahira J, Ishida T, Hirakawa H, Yamaguchi Y, Hayashi S, Sasano H.
    Int J Cancer; 2007 Jan 15; 120(2):285-91. PubMed ID: 17066438
    [Abstract] [Full Text] [Related]

  • 2. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.
    Shibuya R, Suzuki T, Miki Y, Yoshida K, Moriya T, Ono K, Akahira J, Ishida T, Hirakawa H, Evans DB, Sasano H.
    Endocr Relat Cancer; 2008 Mar 15; 15(1):113-24. PubMed ID: 18310280
    [Abstract] [Full Text] [Related]

  • 3. Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment.
    Takagi K, Miki Y, Nagasaki S, Hirakawa H, Onodera Y, Akahira J, Ishida T, Watanabe M, Kimijima I, Hayashi S, Sasano H, Suzuki T.
    Endocr Relat Cancer; 2010 Jun 15; 17(2):415-30. PubMed ID: 20228125
    [Abstract] [Full Text] [Related]

  • 4. 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions.
    Suzuki T, Darnel AD, Akahira JI, Ariga N, Ogawa S, Kaneko C, Takeyama J, Moriya T, Sasano H.
    J Clin Endocrinol Metab; 2001 May 15; 86(5):2250-7. PubMed ID: 11344235
    [Abstract] [Full Text] [Related]

  • 5. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
    Hanamura T, Niwa T, Nishikawa S, Konno H, Gohno T, Tazawa C, Kobayashi Y, Kurosumi M, Takei H, Yamaguchi Y, Ito K, Hayashi S.
    Breast Cancer Res Treat; 2013 Jun 15; 139(3):731-40. PubMed ID: 23780684
    [Abstract] [Full Text] [Related]

  • 6. Androgens in human breast carcinoma.
    Suzuki T, Miki Y, Takagi K, Hirakawa H, Moriya T, Ohuchi N, Sasano H.
    Med Mol Morphol; 2010 Jun 15; 43(2):75-81. PubMed ID: 20683693
    [Abstract] [Full Text] [Related]

  • 7. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders.
    Ito K, Suzuki T, Akahira J, Moriya T, Kaneko C, Utsunomiya H, Yaegashi N, Okamura K, Sasano H.
    Int J Cancer; 2002 Jun 10; 99(5):652-7. PubMed ID: 12115497
    [Abstract] [Full Text] [Related]

  • 8. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
    Miki Y, Suzuki T, Tazawa C, Yamaguchi Y, Kitada K, Honma S, Moriya T, Hirakawa H, Evans DB, Hayashi S, Ohuchi N, Sasano H.
    Cancer Res; 2007 Apr 15; 67(8):3945-54. PubMed ID: 17440110
    [Abstract] [Full Text] [Related]

  • 9. Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast.
    Yoda T, McNamara KM, Miki Y, Takagi M, Rai Y, Ohi Y, Sagara Y, Tamaki K, Hirakawa H, Ishida T, Suzuki T, Ohuchi N, Sasano H.
    Cancer Sci; 2014 Nov 15; 105(11):1503-9. PubMed ID: 25230018
    [Abstract] [Full Text] [Related]

  • 10. Increased 5α-reductase type 2 expression in human breast carcinoma following aromatase inhibitor therapy: the correlation with decreased tumor cell proliferation.
    Chanplakorn N, Chanplakorn P, Suzuki T, Ono K, Wang L, Chan MS, Wing L, Yiu CC, Chow LW, Sasano H.
    Horm Cancer; 2011 Feb 15; 2(1):73-81. PubMed ID: 21761341
    [Abstract] [Full Text] [Related]

  • 11. The role of 5α-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinoma.
    Tanaka S, Miki Y, Hashimoto C, Takagi K, Doe Z, Li B, Yaegashi N, Suzuki T, Ito K.
    Mol Cell Endocrinol; 2015 Feb 05; 401():56-64. PubMed ID: 25475427
    [Abstract] [Full Text] [Related]

  • 12. 5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
    Negri-Cesi P, Colciago A, Poletti A, Motta M.
    Prostate; 1999 Dec 01; 41(4):224-32. PubMed ID: 10544295
    [Abstract] [Full Text] [Related]

  • 13. In situ androgen and estrogen biosynthesis in endometrial cancer: focus on androgen actions and intratumoral production.
    Ito K, Miki Y, Suzuki T, McNamara KM, Sasano H.
    Endocr Relat Cancer; 2016 Jul 01; 23(7):R323-35. PubMed ID: 27287451
    [Abstract] [Full Text] [Related]

  • 14. Aromatase in human breast carcinoma as a key regulator of intratumoral sex steroid concentrations.
    Suzuki T, Miki Y, Akahira J, Moriya T, Ohuchi N, Sasano H.
    Endocr J; 2008 Jul 01; 55(3):455-63. PubMed ID: 18480557
    [Abstract] [Full Text] [Related]

  • 15. Intracrinology of sex steroids in ductal carcinoma in situ (DCIS) of human breast: comparison to invasive ductal carcinoma (IDC) and non-neoplastic breast.
    Miki Y, Suzuki T, Sasano H.
    J Steroid Biochem Mol Biol; 2009 Mar 01; 114(1-2):68-71. PubMed ID: 19444935
    [Abstract] [Full Text] [Related]

  • 16. Intracrinology of estrogens and androgens in breast carcinoma.
    Sasano H, Suzuki T, Miki Y, Moriya T.
    J Steroid Biochem Mol Biol; 2008 Feb 01; 108(3-5):181-5. PubMed ID: 17933521
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.